Ultrasound AI, Inc. , a developer of artificial intelligence for medical imaging with a focus on maternal-fetal health, today announced the issuance of two U.S. patents, bringing its U.S. portfolio to six granted patents. Issued on September 1 and September 15, the patents address pharmaceutical-exposure analysis and comprehensive medical assessment through medical imaging.
The new patents expand the company’s intellectual property portfolio around using artificial intelligence to extract clinically relevant information from medical images. They reflect research extending from Ultrasound AI’s foundations in pregnancy imaging to additional potential applications in medicine.
“Our goal is to turn the information in medical images into insights that help clinicians make more informed decisions,” said Robert Bunn, founder and CEO of Ultrasound AI. “These patents reflect the breadth of our research and strengthen the intellectual property foundation for our work. Our focus remains bringing carefully developed AI into maternal-fetal care, where better information can make a meaningful difference for families.”
The two patents are:
The additions build on Ultrasound AI’s existing U.S. patents concerning premature-birth prediction and the determination of clinical values through medical imaging. The company also holds patents in Israel, Singapore, Japan and South Korea, with additional applications pending in the United States and internationally. The full patent portfolio can be found at ultrasound.ai/patents .
Issued patents cover inventions and methods, and do not reflect the FDA-authorized indications for use of any Ultrasound AI product.
About Delivery Date AI™
Ultrasound AI’s flagship technology, Delivery Date AI™, was granted marketing authorization by FDA through the De Novo pathway earlier this year (DEN250007) as the first technology of its kind to determine a Predicted Delivery Date solely from standard ultrasound images. With these new patents, Ultrasound AI will continue shaping the future of diagnostic imaging. The system is available to practices, hospitals, imaging centers, and ultrasound equipment partners across the United States.
About Ultrasound AI
Ultrasound AI, Inc. is based in Greenwood Village, Colorado, and builds image-only artificial intelligence that augments clinicians with earlier insights. The company’s patented technology predicts delivery timing from standard ultrasound images and is designed to fit seamlessly into existing ultrasound workflows. The company is exploring additional obstetric applications through ongoing research. Learn more at ultrasound.ai .